GNHAF - Vifor Pharma's (GNHAF) Management Discusses Q2 2021 Results - Earnings Call Transcript

Vifor Pharma AG (GNHAF) Q2 2021 Earnings Conference Call August 5, 2021, 8:00 am ET Company Participants Colin Bond - CFO Klaus Jensen - CMO Conference Call Participants Christian Glennie - Stifel James Gordon - JPMorgan Rosie Turner - Barclays Paul Verbraeken - Research Partners Barbora Blaha - Credit Suisse Laura Pfeifer - Octavian Presentation Colin Bond Good afternoon, everyone, and welcome to the 2021 Half Year Results of the Company. The format of the call is the following. I will start with a business update prior to summarizing the financial performance for the first half of 2021. I will conclude the presentation with the outlook and financial guidance for 2021 before opening up the line for questions. My colleague, Klaus Jensen, Chief Medical Officer, will join me for the Q&A session. At a macro level, the first half of 2021 was dominated by the global rollout of the COVID

For further details see:

Vifor Pharma's (GNHAF) Management Discusses Q2 2021 Results - Earnings Call Transcript